The New Federal Definition of Hemp: Legal and Regulatory Implications

Congress has enacted a sweeping revision to the federal definition of hemp through the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (H.R. 5371, Pub. L. No. 119‑37), signed into law on November 12, 2025. This amendment represents the most consequential change since the Agricultural Improvement Act of 2018 (2018 Farm Bill) and will take effect on November 12, 2026, with full enforcement beginning January 1, 2027

The Updated Definition

Under the revised statute, hemp will no longer be defined solely by its Delta-9 THC concentration on a dry-weight basis. Instead, the definition incorporates production methods, intended effects, and total THC content per container.

The Act amends 7 U.S.C. § 1639o(1), redefining hemp as:

“The plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a concentration of not more than 0.4 milligrams of total tetrahydrocannabinols per container, and excluding any product containing synthesized cannabinoids or marketed for intoxicating effects.”

Key provisions include:

• THC Threshold: Products exceeding 0.4 milligrams of total THC per container will be excluded from the lawful hemp category.
• Synthetic Cannabinoids: Any product containing synthesized cannabinoids or marketed for intoxicating effects will be classified outside the scope of lawful hemp.
• FDA Oversight: Within 90 days of enactment, the FDA must publish foundational lists identifying:
  • Cannabinoids naturally produced by Cannabis sativa L.
  • The definition of a “container” for hemp products.

Industry Impact

The hemp industry, valued at approximately $28.4 billion and supporting an estimated 300,000 jobs, faces substantial disruption.

• Market Contraction: Intoxicating hemp products, including edibles and beverages, may be reclassified as controlled substances.
• Intoxicating hemp products (e.g., Delta‑8 THC gummies, beverages) may be reclassified as controlled substances under the Controlled Substances Act (CSA), 21 U.S.C. §§ 801 et seq.
• State-Federal Conflicts: States such as Tennessee have already implemented regulations on intoxicating cannabinoids. The federal definition may override or complicate these frameworks, leading to litigation and compliance challenges.
• Operational Uncertainty: Businesses must reassess product lines, labeling, and distribution channels to avoid federal enforcement actions.

Legal and Regulatory Challenges

The revised definition blurs the distinction between hemp and marijuana, raising complex legal questions:

• Compliance Risks: Operators must navigate conflicting guidance from Congress, the FDA, and the Department of Justice, with heightened risk of federal crackdowns.
• Absence of Spending Restrictions: Unlike marijuana, hemp businesses lack federal appropriations riders that limit enforcement, leaving them exposed to regulatory action.
• Litigation Potential: The interplay between federal and state laws is likely to generate constitutional and administrative challenges, particularly concerning interstate commerce and preemption.
• Conflicting guidance: Operators must reconcile directives from Congress, FDA, and DOJ, with heightened risk of federal crackdowns.
• No appropriations protections: Unlike marijuana, hemp businesses lack federal spending restrictions that limit enforcement, leaving them vulnerable to DOJ action
• Litigation potential: The interplay between federal and state laws is likely to generate constitutional challenges, particularly regarding interstate commerce and preemption.

Strategic Considerations for Stakeholders

Stakeholders in the hemp, marijuana, and alcohol industries should proactively evaluate their exposure under the new definition. Recommended steps include:

• Regulatory Audits: Conduct comprehensive reviews of product portfolios to identify items at risk of reclassification.

• Compliance Planning: Develop strategies for reformulation, labeling, and marketing to align with federal standards.

• Legal Preparedness: Anticipate potential enforcement actions and prepare for litigation involving federal preemption and state regulatory conflicts.

• Industry Advocacy: Engage in lobbying and public comment processes to influence FDA rulemaking and congressional oversight.

Conclusion

The new federal definition of hemp marks a decisive shift in cannabis regulation, closing the “intoxicating hemp loophole” and imposing stricter controls on THC content and synthetic cannabinoids. While intended to provide clarity, the law introduces significant uncertainty for operators and investors. The coming year will be critical in determining whether hemp-derived consumer products remain viable under federal law.

Track and review more Government Bills (If you want)

• Recap 11/21/25

Established in 1993, Komorn Law  has decades of experience navigating the complexities of Michigan’s cannabis landscape, from the early days of medical marijuana (MMMA) to the regulatory challenges and constitutional fights of the current adult-use market (MRTMA).

As Michigan’s cannabis community confronts aggressive tax hikes, legislative attempts to rewrite the people’s laws, and ongoing criminal charges stemming from the state’s Public Health Code, the need for experienced legal counsel is paramount. Komorn Law has the expertise and deep institutional knowledge to fight your case in a court of law, from the district to federal court systems, challenging not only individual charges but also the regulatory schemes and constitutional infringements that threaten the industry and individual rights. When you’re ready to hire a lawyer who hates to lose, call our office  248-357-2550.